Trulieve Cannabis Subordinate Voting Shares Quarterly Cash Flow Statement
NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Trulieve Cannabis Subordinate Voting Shares free cash flow
In the quarter ended Jun 30, 2026, Trulieve Cannabis Subordinate Voting Shares generated $53.1 million of operating cash flow and spent $21.0 million on capital expenditures. That left free cash flow of $32.1 million, a free-cash-flow margin of 11.9% of revenue. Free cash flow was down 56.9% from the prior year's $74.5 million.
Summary generated from market data by MetaCap's automated system. Methodology
Trulieve Cannabis Subordinate Voting Shares cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -406.06M | 2.28M | -43.59M | -28.78M | -16.11M | -33.76M | -61.56M | -61.86M | -12.31M | -24.85M | -34.79M | -25.84M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 25.72M | 29.74M | 29.42M | 29.46M | 29.43M | 29.33M | 28.64M | 28.33M | 28.08M | 27.75M | 27.20M | 26.96M |
| Stock-Based Compensation | 6.91M | 4.14M | 3.98M | 5.79M | 6.76M | 3.94M | 4.62M | 5.47M | 4.96M | 5.15M | 3.16M | 4.54M |
| Change in Working Capital | -15.86M | -14.98M | 3.38M | 2.75M | -7.48M | -18.79M | -7.17M | -3.70M | -7.71M | 5.42M | 19.47M | 31.98M |
| Operating Cash Flow | 53.14M | 55.71M | 59.22M | 76.38M | 86.09M | 51.13M | 30.68M | 30.34M | 71.32M | 139.15M | 131.46M | 93.44M |
| Capital Expenditures | -21.01M | -13.48M | -3.41M | -12.33M | -11.57M | -16.88M | -42.70M | -38.12M | -26.29M | -15.49M | -9.24M | -6.28M |
| Investing Cash Flow | -74.86M | -13.19M | -5.89M | -14.99M | -8.63M | 43.02M | -23.18M | -131.49M | -32.98M | -18.96M | -7.16M | -4.99M |
| Debt Issued | 0 | 60.74M | — | — | 0 | 0 | — | — | — | — | — | — |
| Financing Cash Flow | -5.74M | 54.83M | -255.39M | -4.77M | -5.83M | -4.50M | -6.36M | -16.36M | -9.17M | -1.55M | -114.99M | -51.26M |
| Net Change in Cash | -27.46M | 97.34M | -202.07M | 56.62M | 71.63M | 89.65M | 1.14M | -117.52M | 29.17M | 118.64M | 9.32M | 37.19M |
| Free Cash Flow | 32.13M | 42.22M | 55.80M | 64.05M | 74.53M | 34.25M | -12.02M | -7.78M | 45.03M | 123.66M | 122.22M | 87.16M |
This table shows 12 quarterly periods of Trulieve Cannabis Subordinate Voting Shares's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow TRLV's reporting calendar. What is a cash flow statement?